$EQBK

Rogerson Donald Scott purchased $100K of EQBK

Rogerson Donald Scott purchased 2,000 shares of EQUITY BANCSHARES INC (EQBK) at $50.25 ($0.10M total) on 2026-07-31.

Original reporting
SEC EDGAR · Rogerson Donald Scott
Published Aug 3, 2026, 9:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 3, 2026, 9:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EQBK
Bullish
low confidence
Mentioned
$EQBK
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EQBKBullishLow
01

Why it matters

A director open-market purchase was reported, but there is no accompanying company event (earnings, guidance, deal, or regulatory action) that would materially reset valuation expectations.

02

Market read

Traders may note mild bullish sentiment from insider buying, but the filing alone is unlikely to be a standalone catalyst.

03

What to watch

The filing does not state intent, motivation, or whether the director’s broader trading pattern supports a directional thesis; also, no 10b5-1 plan is noted, but that alone does not confirm conviction.

Relevance 5/10Novelty 3/10Timing: filed after-hours on 2026-08-03, referencing a 2026-07-31 purchase

Background

The article is a SEC Form 4 insider transaction disclosure for Equity Bancshares Inc (EQBK).

Company-level read

Ticker impact

$EQBKBullishLow confidence
Context

EQBK director Rogerson Donald Scott filed a Form 4 for an open-market purchase of 2,000 shares at $50.25 on 2026-07-31.

Expected impact

Likely limited near-term impact; any effect is more sentiment-driven than fundamental.

Evidence & confidence

The disclosure is primary-source but the transaction size is modest and the filing provides no new guidance, contract, or regulatory development for EQBK.

Market effects

No sector read-through is provided beyond a single bank insider transaction.

None indicated.

None indicated.

Counterpoint

Insider purchases can be discretionary or part of routine compensation/financial planning, so the signal may be weak.

Key entities

  • Equity Bancshares Inc

    Subject of the Form 4 insider transaction disclosure.

  • Rogerson Donald Scott

    Director who purchased 2,000 shares of EQBK at $50.25 on 2026-07-31.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$EQBKMed

Equity Bancshares (EQBK) Q3 2026 Earnings Call Transcript

Equity Bancshares (EQBK) reported Q3 2026 earnings, highlighting organic growth with loans up $39M to $5.44B and deposits down $136M to $6.17B. The company announced a merger with Lincoln Bancorp, adding 16 branches in Iowa. Net income was $26.8M, or $1.29 per diluted share. The company expects margin to return to 4.25-4.35% in Q4, excluding the merger.

$EQBKMed

StoneX lowers Equity Bancshares stock price target on NIM outlook

StoneX reduced its price target for Equity Bancshares (EQBK) to $58 from $59, citing net interest margin expectations. The firm raised its fiscal 2026 EPS forecast to $5.18 but lowered the 2027 estimate to $5.27. EQBK's stock trades at a P/E ratio of 10.58, and analysts expect net income growth. The company recently reported Q3 earnings beating estimates, with EPS of $1.40 vs. $1.29 expected, but revenue missed slightly.

$EQBKMed

Equity Bancshares Q3 2026 slides: EPS beats amid margin pressure

Equity Bancshares (EQBK) reported Q3 2026 earnings of $1.40 per share, beating estimates, though revenue fell slightly short. The stock rose 0.99% to $47.03. The bank faces margin pressure but continues growth through acquisitions, including the pending Lincoln Savings Bank deal. Asset quality showed some deterioration, with nonperforming assets rising to 0.99%. The company is investing in AI to improve efficiency.

$EQBKMed

Equity Bancshares (EQBK) Posts Solid Net Interest Income Despite

Equity Bancshares (EQBK) reported Q2 2026 net interest income of $72.8M, down slightly from the prior quarter but up 16.6% year-over-year. The company's GF Value™ suggests it is modestly undervalued with a 15.2% margin of safety. EQBK has a GF Score™ of 81/100, indicating strong fundamentals in valuation and momentum, but weaker financial strength. Insiders and gurus have shown net selling activity. The stock trades at $46.57 with a trailing P/E of 27.97x and a forward P/E of 8.55x.